• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Thromb Res . Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort stud

tetano

Editor, Senior Moderator
Thromb Res


. 2020 Jul 9;195:62-68.
doi: 10.1016/j.thromres.2020.07.015. Online ahead of print.
Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study


Ying-Yi Luan[SUP] 1 [/SUP], Yan Liu[SUP] 1 [/SUP], Xue-Yan Liu[SUP] 2 [/SUP], Bao-Jun Yu[SUP] 3 [/SUP], Rong-Ling Chen[SUP] 4 [/SUP], Mian Peng[SUP] 5 [/SUP], Di Ren[SUP] 1 [/SUP], Hao-Li Li[SUP] 1 [/SUP], Lei Huang[SUP] 6 [/SUP], Yong Liu[SUP] 7 [/SUP], Jin-Xiu Li[SUP] 8 [/SUP], Yong-Wen Feng[SUP] 9 [/SUP], Ming Wu[SUP] 10 [/SUP]



Affiliations

Abstract

Background: Early detection of suspected critical patients infected with coronavirus disease 2019 (COVID-19) is very important for the treatment of patients. This study aimed to investigate the role of COVID-19 associated coagulopathy (CAC) to preview and triage.
Methods and results: A cohort study was designed from government designated COVID-19 treatment center. CAC was defined as International Society on Thrombosis and Haemostasis (ISTH) score ≥2. Data from 117 patients COVID-19 were reviewed on admission. The primary and secondary outcomes were admission to Intensive Care Unit (ICU), the use of mechanical ventilation, vital organ dysfunction, discharges of days 14, 21 and 28 from admission and hospital mortality. Among them, admission to ICU was increased progressively from 16.1% in patients with non-CAC to 42.6% in patients with CAC (P < 0.01). Likely, invasive ventilation and noninvasive ventilation were increased from 1.8%, 21.4% in patients with non-CAC to 21.3%, 52.5% in patients with CAC, respectively (P < 0.01). The incidences of acute hepatic injury and acute respiratory distress syndrome in non-CAC and CAC were 28.6% vs. 62.3%, 8.9% vs. 27.9%, respectively (P < 0.01). The discharges of days 14, 21 and 28 from admission were more in non-CAC than those of CAC (P < 0.05). Multiple logistic regression results showed that ISTH score ≥2 was obviously associated with the admission to ICU (OR 4.07, 95% CI 1.47-11.25 P = 0.007) and the use of mechanical ventilation (OR 5.54, 95% CI 2.01-15.28 P = 0.001) in patients with COVID-19.
Conclusion: All results show ISTH score ≥2 is an important indicator to preview and triage for COVID-19 patients.

Keywords: Coagulopathy; Coronavirus disease 2019; ISTH score; Mechanical ventilation; Outcome.
 
Back
Top Bottom